Lifitegrast Impurity 125 is a benzotriazolyl ester derivative of a dichloro-dihydroisoquinolinecarbonyl benzofuran compound, used as a pharmaceutical impurity reference standard for quality control in lifitegrast manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2889431-14-3
N-[5-(Diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl]-N-methylmethanesulfonamide
pharmaceutical intermediate
Tert-Butyl 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetate
pharmaceutical intermediate
N-nitroso-tamsulosin
pharmaceutical intermediate
Maupiti Airport
pharmaceutical intermediate
benzotriazol-1-yl 2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carboxylate
MKQYGFRVHFWWPY-UHFFFAOYSA-N
C1CN(CC2=CC(=C(C(=C21)Cl)C(=O)ON3C4=CC=CC=C4N=N3)Cl)C(=O)C5=CC6=C(C=C5)C=CO6